account_balance
Investment manager · 13F filer · SEC CIK 2010850
Decheng Capital LLC
Reported value$732Mas of Jun 30, 2026
Positions14 1 new, 1 sold out
Top 10 weight98%CGON alone is 62%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
CGON
Cg Oncology Inc
61.9%
NUVB
Nuvation Bio Inc.
20.1%
AARD
Aardvark Therapeutics Inc
3.1%
ACRS
Aclaris Therapeutics, Inc.
2.9%
UPB
Upstream Bio Inc.
2.6%
RCUS
Arcus Biosciences, Inc
2.0%Trimmed
EQ
Equillium Inc.
1.9%
RVMD
1.3%
Lyell Immunopharma, Inc.
1.3%
BYSI
0.9%
4 others
1.9%
Box size is the share of the fund's reported holdings. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
What changed